NCT01810718 Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD Status COMPLETED Phase PHASE1
NCT01680965 Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01526850 Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease Status UNKNOWN Phase PHASE2/PHASE3
NCT01380535 Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD) Status COMPLETED Phase EARLY_PHASE1
NCT00815919 Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease Status COMPLETED Phase PHASE2